Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Chan

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Life Sciences|January 1, 1995
Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primatesG L Chan, D J Doudet, T Dobko, et al.
Basic Life Sciences|January 1, 1984
Study of basal cell nevus syndrome fibroblasts after treatment with DNA-damaging agentsH Nagasawa, F F Little, M J Burke, et al.
Synapse (New York, N.Y.)|June 23, 1998
6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeysD J Doudet, G L Chan, J E Holden, et al.
Pharmacotherapy|January 1, 1990
The pharmacoeconomics of renal transplantation: increased drug costs with decreased hospitalization costsD M Canafax, S A Gruber, G L Chan, et al.
European Journal of Pharmacology|November 5, 1997
Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPAD J Doudet, G L Chan, J E Holden, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 17, 1999
Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosineD J Doudet, G L Chan, S Jivan, et al.
Frontiers in Chemistry|May 3, 2024
Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by pieceBill W G L Chan, Nicholas B Lynch, Wendy Tran, et al.
Transplantation|July 1, 1991
Encephalopathy associated with OKT3 administration. Possible interaction with indomethacinG L Chan, S S Weinstein, C E Wright, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 1999
Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjectsG L Chan, J E Holden, A J Stoessl, et al.
Synapse (New York, N.Y.)|August 15, 1998
Age-dependent decline of dopamine D1 receptors in human brain: a PET studyY Wang, G L Chan, J E Holden, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Life Sciences|January 1, 1995
Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primatesG L Chan, D J Doudet, T Dobko, et al.
Basic Life Sciences|January 1, 1984
Study of basal cell nevus syndrome fibroblasts after treatment with DNA-damaging agentsH Nagasawa, F F Little, M J Burke, et al.
Synapse (New York, N.Y.)|June 23, 1998
6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeysD J Doudet, G L Chan, J E Holden, et al.
Pharmacotherapy|January 1, 1990
The pharmacoeconomics of renal transplantation: increased drug costs with decreased hospitalization costsD M Canafax, S A Gruber, G L Chan, et al.
European Journal of Pharmacology|November 5, 1997
Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPAD J Doudet, G L Chan, J E Holden, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 17, 1999
Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosineD J Doudet, G L Chan, S Jivan, et al.
Frontiers in Chemistry|May 3, 2024
Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by pieceBill W G L Chan, Nicholas B Lynch, Wendy Tran, et al.
Transplantation|July 1, 1991
Encephalopathy associated with OKT3 administration. Possible interaction with indomethacinG L Chan, S S Weinstein, C E Wright, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 1999
Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjectsG L Chan, J E Holden, A J Stoessl, et al.
Synapse (New York, N.Y.)|August 15, 1998
Age-dependent decline of dopamine D1 receptors in human brain: a PET studyY Wang, G L Chan, J E Holden, et al.
Pageof 7